CURRICULUM VITAE. Jonathan Dickerson B.S. Biology, Wilmington College.

Similar documents
KATRINA PAUMIER CURRICULUM VITAE

JOURNAL OF NEUROINFLAMMATION

Current Position. Education. Awards & Honors

Nicholas W. Simon Ph.D. Curriculum Vitae

Neurobiology and Behavior, Ph.D. in progress University of California, Irvine; Irvine, CA

Classes of Neurotransmitters. Neurotransmitters

B.S. in Psychology University of Georgia, Athens, GA. Minor: Statistics. Magna Cum Laude. Phi Beta Kappa Honor Society. GPA: 3.84

The role of FGF-9 expression in neuroprotection of melatonin and MPP + -induced parkinsonism model in vivo and in vitro Key words: FGF-9; melatonin;

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

CURRICULUM VITAE present: Associate Professor, Pharmaceutical Sciences School of Pharmacy, Palm Beach Atlantic University

B.S. in Psychology University of Georgia, Athens, GA. Minor: Statistics. Magna Cum Laude. Phi Beta Kappa Honor Society. GPA: 3.84

Outline. Outline. Background Literature and Slides 10/23/2013. The Schizophrenia Research Forum online: Molecules, Neural Networks and Behavior

Curriculum Vitae Andrew J. Butler, Ph.D.

C. Brock Kirwan, Ph.D.

Voice: (802)

TITLE: Neurotrophic Response to CNS Degeneration or Injury: Effects of Aging

EMPLOYMENT Research Analyst, Vanderbilt Department of Psychology, Nashville, TN (May 2010 July 2012)

- Neurotransmitters Of The Brain -

LAUREN C. ANDERSON Boston College, Department of Psychology Chestnut Hill, MA

Neurobiology and Behavior, Ph.D. in progress University of California, Irvine; Irvine, CA

Schizophrenic twin. Normal twin

22 JWA :00-15:


Schizophrenia & the Antipsychotics

Strategies for Neurorestoration: Growth Factors

ESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal

EDUCATION RESEARCH EXPERIENCE

Drugs, the Brain, and Behavior SECOND EDITION. Chapter 17, Environmental Neurotoxicants and Endocrine Disruptors

Cellular and molecular mechanisms of memory storage Synaptic plasticity and Alzheimer s disease Reward learning and addiction

Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson s Disease

Modeling Parkinson s disease: systems to test gene-environment interactions

VICTORIA LAURA DESENSI CURRICULUM VITAE Wild Plum Court Phone: (440)

DRUG TREATMENT OF PARKINSON S DISEASE. Mr. D.Raju, M.pharm, Lecturer

35 Gedney Rd

Kimberly E. Lanni, Ph.D.

Down regulation of the HCN2 channel in rat models of Parkinson s disease

475 GERIATRIC PSYCHOPHARMACOLOGY (p.1)

Parkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817.

Demystifying the Cell Biology of Cancer

Basal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota

Exam 2 PSYC Fall (2 points) Match a brain structure that is located closest to the following portions of the ventricular system

GBME graduate course. Chapter 43. The Basal Ganglia

Advanced Receptor Psychopharmacology

Elias B Issa, PhD. Curriculum Vitae 10/2015

The role of pramipexole in a severe Parkinson s disease model in mice

Neuropharmacology NOTES

Cogs 107b Systems Neuroscience lec9_ neuromodulators and drugs of abuse principle of the week: functional anatomy

Education and Training: NYU Langone Medical Center, New York, NY Post-doctoral Fellow Advisor: Alexander Neumeister/Charles Marmar

Catherine Fassbender, Ph.D.

Curriculum Vitae. Neil David Woodward, Ph.D.

The Nervous System Mark Stanford, Ph.D.

Curriculum Vitae Clare J. Wilhelm, Ph.D.

SARAH HOPE LINCOLN Clinical and Research Fellow, Div. of Child and Adolescent Psychiatry, McLean Hospital

ASSAF HAREL, PHD CURRICULUM VITAE Department of Psychology Wright State University

Shift 1, 8 July 2018, 09:30-13:00

Do we still believe in the dopamine hypothesis? New data bring new evidence

West Virginia University School of Medicine, Morgantown, West Virginia

Teach-SHEET Basal Ganglia

Visualization and simulated animations of pathology and symptoms of Parkinson s disease

Movement Disorders: A Brief Overview

Biobehavioral Health Advisor: Stephanie Lanza, Ph.D.

Elias B Issa, PhD. Curriculum Vitae 08/2016. RESEARCH INTEREST The neural mechanisms and computational principles underlying high-level vision

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

CURRICULUM VITAE Sarah Hope Lincoln

Marieke R. Gilmartin, Ph.D.

CURRICULUM VITAE. Robert W Sikes PhD. Address:

Cover Page. The handle holds various files of this Leiden University dissertation.

CURRICULUM VITAE: DOUGLAS W. HEINRICHS, MD. License: Licensed to practice medicine in Maryland 1978 to present (D22279)

Making Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease

CURRICULUM VITAE STEPHEN ROBERT HAYS, MD, FAAP

Sarah A. Woller Texas A&M Institute for Neuroscience Department of Psychology College Station, TX

Biomarkers in Schizophrenia

Switching Antipsychotics in HIV Patients Focus on Aripiprazole

Synapses and Neurotransmitters.

EDUCATION FULL-TIME ACADEMIC EXPERIENCE

What do you notice?

CURRICULUM VITAE September 2005 SUSAN E. BAKER

Deranda B. Lester, Ph.D. Curriculum Vitae

Patricia A. Lipscomb, M.D., Ph.D. CURRICULUM VITAE

Treatment of Parkinson s Disease and of Spasticity. Satpal Singh Pharmacology and Toxicology 3223 JSMBS

Sensory Gating Measures. Auditory P50 Response Prepulse Inhibition of Startle (PPI) Bruce Turetsky, M.D. IOM Workshop June 22, 2010

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Preclinical Psychopharmacology: From Mechanisms & Molecules to Medicines

A. Personal Statement

Ashley M. Kopec, Ph.D. Curriculum Vitae November 8, th Street Lab Tel: rd Floor; Bilbo Lab

Effects of stress-induced depression on Parkinson s disease symptomatology

PERCEPTION: Gain Control & Integration. Mark A. Geyer, Ph.D. Departments of Psychiatry & Neurosciences University of California, San Diego

Psychotropic Drugs Critical Thinking - KEY

TITLE: Pharmacological and Behavioral Enhancement of Neuroplasticity in the MPTP- Lesioned Mouse and Nonhuman Primate.

Effects of nicotine on neuronal firing patterns in human subthalamic nucleus. Kim Scott Mentor: Henry Lester SURF seminar, January 15, 2009

Parkinson s disease (PD) is a neurodegenerative disorder that mainly affects individuals

CURRICULUM VITAE Krystal L. Parker, Ph.D. Page 1 of 6

Pushing the plasticity: The role of exercise in the management of neurological illness

CURRICULUM VITAE. Jacob Patrick Schwarz. Neurosurgical Associates Nashville, Tennessee

Divisional Director of International Clinical Research Mood & Anxiety Disorders. Year Education Education institution

Neurotransmitter: dopamine. Physiology of additive drugs. Dopamine and reward. Neurotransmitter: dopamine

NEUROPLASTICITY IN THE NIGROSTRIATAL SYSTEM OF MPTP-TREATED MICE AT THE PRESYMPTOMATIC AND EARLY SYMPTOMATIC STAGES OF PARKINSONISM

Ahu Gökçe, Ph.D. Department of Psychology Kadir Has University

Stephen L. P. Lippi, Ph.D Appaloosa Trail, Apt San Angelo, TX Phone:

Damage on one side.. (Notes) Just remember: Unilateral damage to basal ganglia causes contralateral symptoms.

Transcription:

CURRICULUM VITAE Jonathan Dickerson Education: 1999-2003 B.S. Biology, Wilmington College. 2004-2010 Ph.D., Neuroscience Graduate Program, University of Cincinnati. Thesis Advisor: Dr. Kim Seroogy 2007 Admission to Candidacy, Doctor of Philosophy Degree Honors: Wilmington College: 1999-2003 Honors Program 1999-2003 Presidential Scholarship 1999-2003 Cuyahoga County Scholarship 2002-2003 Green Key Society 2003 Magna Cum Laude University of Cincinnati: 2005-2006 Functional Genomics Fellowship 2007-2009 Scottish Rite Schizophrenia Research Fellowship Research Experience: 2000-2002 Summer Research Assistant Laboratory of Dr. Frank Sharp University of Cincinnati 2003-2004 Laboratory Research Assistant Laboratory of Dr. Frank Sharp

University of Cincinnati 2004 Research Rotation Department of Developmental Biology Laboratory of Dr. Charles Voorhees Cincinnati Children s Research Foundation 2004-2010 Graduate Assistant Laboratory of Dr. Kim Seroogy University of Cincinnati 2010-present Postdoctoral Fellow Department of Pharmacology Laboratory of Dr. P.J. Conn Vanderbilt University Committees 2007 Organizing Committee; Neuroscience Day, Ohio Miami Valley Chapter, Society for Neuroscience Techniques Learned: Tissue sectioning: microtome, cryostat, & vibratome Immunohistochemistry Computer image analysis Administration of drugs to animals Animal models of PD and Schizophrenia Stereotaxic surgery In situ hybridization Behavior analysis of neurotoxin lesions Western blotting Stereology Professional Societies: 2005-2009 Ohio Miami Valley Chapter, Society for Neuroscience 2006-2009 Society for Neuroscience Journal Reviews: 2007 Journal of Chemical Neuroanatomy

Bibliography Peer-Reviewed Journal Articles Carter, K., Dickerson, J., Schoepp, D.D., Reilly, M., Herring, N., Williams, J., Sallee, F.R., Sharp, J.W., and Sharp, F.R. (2004) The mglu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis. Neuropharmacology. 47: 1135-1145. Dickerson, J., and Sharp, F.R. (2006) Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801. Neuropsychopharmacology. 31: 1420-1430. Dickerson, J.W., Hemmerle, A.M., Numan, S., Lundgren, K.H., and Seroogy, K.B. (2009). Decreased expression of ErbB4 and tyrosine hydroxylase mrna and protein in the ventral midbrain of aged rats. Neuroscience. 163: 482-489. Suidan, G.L., Dickerson, J.W., Chen, Y., Mcdole, J.R., Tripathi, P., Pirko, I., Seroogy, K.B., Johnson, A.J. (2010). CD8 T cell-mediated VEGF expression promotes CNS vascular permeability under neuro-inflammatory conditions. J. Immunol. 184: 1031-1040. Hemmerle, A.M., Dickerson, J.W., Herring, N.R., Schaefer, T.L., Vorhees, C.V., Williams, M.T., and Seroogy, K.B. (2010). (±)3,4-Methylenedioxymethamphetamine (ecstasy) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain. J. Comp. Neurol. In revision. Dickerson, J.W. *, Suidan, G.L. *, Pirko, I., Seroogy, K.B., Johnson, A.J. (2010). VEGF receptor alterations in a murine model of CNS vascular permeability. In Preparation. (* denotes authors contributed equally). Dickerson, J.W., Hemmerle, A.M., Lundgren, K.H., and Seroogy, K.B. (2010). Supranigral infusion of GGF2 or NRG 2β improves behavioral function and reduces 6-OHDA-induced cell death in an animal model of Parkinson s disease. In Preparation. Published Abstracts Dickerson, J., Ardizzone, T., Mikulich, S., McKinney, D., Reilly, M., and Sharp, F.R. (2004) Atypical neuroleptics and a Src inhibitor (PP1) prevent the injury produced by NMDA receptor antagonists in adult rat retrosplenial cortex: possible relationship to treatment of psychosis. Soc. Neurosci. Abstr. #350.14.

Numan, S., Dickerson, J.W., Hemmerle, A.M., Lundgren, K.H., and Seroogy, K.B. (2005) Decreased expression of ErbB-4 receptor mrna and protein in the ventral midbrain of aged rats. Soc. Neurosci. Abstr. #214.6. Hemmerle*, A.M., Dickerson*, J.W., Herring, N.R., Schaefer, T.L., Vorhees, C.V., Williams, M.T., and Seroogy, K.B. (2006) Increased Expression of BDNF and trkb mrnas in adult prefrontal cortex and/or striatum after MDMA administration. Soc. Neurosci. Abstr. #478.17. (* denotes authors contributed equally) Herring, N.R., Schaefer, T.L., Dickerson, J.W., Hemmerle, A.M., Vorhees, C.V., Seroogy, K.B., and Williams, M.T. (2006) Neurotoxic methamphetamine (MA) administration increases BDNF in cortical regions and TrkB in striatum of adult rats. Soc. Neurosci. Abstr. #390.18. Dickerson, J.W., Hemmerle, A.M., Lundgren, K.H., and Seroogy, K.B. (2007) Supranigral infusion of neuregulins improves behavioral recovery in a partial-lesion model of Parkinson s disease. Soc. Neurosci. Abstr. #590.6. Seroogy, K.B., Hemmerle, A.M., Dickerson, J.W., Herring, N.R., Schaefer, T.L., Vorhees, C.V., and Williams, M.T. (2007) MDMA administration modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain. Soc. Neurosci. Abstr. #66.3. Hemmerle, A.M., Dickerson, J.W., Lundgren, K.H., Packard, B.A., Jones, K.R., Herman, J.P., and Seroogy, K.B. (2007) Chronic variable stress induces alterations in neurotrophic factor and neurotransmitter synthesizing enzyme expression within the mesotelencephalic system of adult male rats. Soc. Neurosci. Abstr. #908.17. Dickerson, J.W., Suidan, G.L., Pirko, I., Seroogy, K.B., and Johnson, A.J. (2008) Modulated expression of VEGF and its receptors in a novel murine model of vascular permeability. Soc. Neurosci. Abstr. #749.2. Hemmerle, A.M., Dickerson, J.W., Packard, P.A., Dolgas, C.M., Jones, K.R., Herman, J.P., and Seroogy, K.B. (2008) Temporal effects of chronic variable stress on dopaminergic cell degeneration and motor deficits in a partial lesion model of Parkinson s disease. Soc. Neurosci. Abstr. #741.13 Suidan, G.L., Dickerson, J.W., Seroogy, K.B., Pirko, I., and Johnson, A.J. (2008) Rapid induction of VEGF by CD8 T cells precedes CNS vascular permeability. Soc. Neurosci. Abstr. #708.5. Paumier, K.L., Sortwell, C.E., Daley, B.F., Terpstra, B.T., Madhavan, L.M., Levine, N.D., Hemmerle, A.M., Dickerson, J.W., Seroogy, K.B., and Collier, T.J. (2008) Chronic antidepressant treatment is neuroprotective in a rodent model of Parkinson s disease. Soc. Neurosci. Abstr. #247.7.

Suidan, G.L., Dickerson, J.W., Seroogy, K.B., Pirko, I., and Johnson, A.J. (2008) Rapid induction of VEGF by CD8 T cells precedes CNS vascular permeability. OMVSfN. Johnson, A.J., Suidan, G.L., Dickerson, J.W., Chen, Y., Seroogy, K.B., and Pirko, I. (2008) Rapid upregulation of CNS VEGF is initiated by CD8 T cells in a murine model of BBB disruption. Amer. Assoc. Immuno. Annual Meeting. Dickerson, J.W., Suidan, G.L., Johnson, A.J. and Seroogy, K.B. (2009) Decreased expression of ErbB receptor mrnas in brain after induction of CNS vascular permeability. Soc. Neurosci. Abstr. #338.11. Suidan, G.L., Dickerson, J.W., Pirko, I., Seroogy, K.B., and Johnson, A.J. (2009) CD8 T cells initiate rapid induction of neuronal VEGF expression during CNS vascular permeability. Soc. Neurosci. Abstr. #801.4 Dickerson, J.W., Hemmerle, A.M., Lundgren, K.H., Iaci, J.F., Caggiano, A., and Seroogy, K.B. (2010) Supranigral infusion of GGF2 in aging rats protects against dopaminergic cell death and improves motor function in a 6-OHDA lesion model of Parkinson s disease. Soc. Neurosci. Abstr. #751.23 Hemmerle, A.M., Dickerson, J.W., Lundgren, K.H., and Seroogy, K.B. (2010) Age related reduction of ErbB receptor mrna and protein in the substantia nigra of Sprague Dawley rats. Soc. Neurosci. Abstr. #857.20